Drug-induced QT-interval prolongation: considerations for clinicians.

Li, Edward C; Esterly, John S; Pohl, Shaunte; Scott, Shane D; McBride, Brian F

Li, Edward C; Esterly, John S; Pohl, Shaunte; Scott, Shane D; McBride, Brian F.

Affiliation

Li EC; National Comprehensive Cancer Network, Fort Washington, Pennsylvania, USA.

Pharmacotherapy ; 30(7): 684-701, 2010 Jul.

Article in En | MEDLINE | ID: mdl-20575633

Subject(s)

Drug-Related Side Effects and Adverse Reactions; Heart/physiopathology; Action Potentials/physiology; Anti-Arrhythmia Agents/adverse effects; Arrhythmias, Cardiac/chemically induced; Arrhythmias, Cardiac/complications; Death, Sudden, Cardiac/etiology; Death, Sudden, Cardiac/prevention & control; Diagnostic Uses of Chemicals; Electrocardiography/adverse effects; Humans; Pharmaceutical Preparations

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / Heart Type of study: Etiology_studies Limits: Humans Language: En Journal: Pharmacotherapy Year: 2010 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google